Flt3-ligand induces transient tumor regression in an ectopic treatment model of major histocompatibility complex-negative prostate cancer

Cancer Research

Volumn 60, Issue 8, 2000, Pages 2081-2084

  Ciavarra, Richard P ^a   Somers, Kenneth D ^a   Brown, Roy R ^a   Glass, William F ^a   DeAngelis Consolvo, Patricia J ^a   Wright, George L ^a,b   Schellhammer, Paul F ^a,b  

^a EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

^b Sentara Cancer Network   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER RECURRENCE; CANCER TRANSPLANTATION; CELL CULTURE; CELL INFILTRATION; IMMUNOTHERAPY; LIGAND BINDING; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROSTATE CANCER; REGRESSION ANALYSIS; TUMOR GROWTH;

ANIMALS; CELL DIVISION; DISEASE PROGRESSION; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; HISTOCOMPATIBILITY ANTIGENS CLASS I; IMMUNOHISTOCHEMISTRY; IMMUNOTHERAPY; INTERFERON TYPE II; MACROPHAGE ACTIVATION; MALE; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MONOCYTES; NEOPLASM RECURRENCE, LOCAL; NEOPLASM TRANSPLANTATION; PROSTATIC NEOPLASMS; RATS; REMISSION INDUCTION; TUMOR CELLS, CULTURED;

EID: 0034655099     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Landis, S. H., Murray, T., Bolden, S., and Wingo, P. A. Cancer statistics, 1999. CA Cancer J. Clin., 48: 6-29, 1999.
2. Tjoa, B. A., Simmons, S. J., Elgamal, A., Rogers, H., Ragde, H., Kenny, G. M., Troychak, M. J., Boynton, A. L., and Murphy, G. P. Follow-up evaluation of a Phase II prostate cancer vaccine trial. Prostate, 40: 125-129, 1999.
3. Sanda, M. G., Restifo, N. P., Walsh, J. C., Kawakami, Y., Y., Nelson, W. G., Pardoll, D. M., and Simons, J. W. Molecular characterization of defective antigen processing in human prostate cancer. J. Natl. Cancer lnst., 87: 280-285, 1995.
4. Blades, R. A., Keating, P. J., McWilliam, L. J., George, N. J., and Stern, P. L. Loss of HLA class I expression in prostate cancer: implications for immunotherapy. Urology, 46: 681-687, 1995.
5. Lyman, S. D. Biology of Flt3 ligand and receptor. Int. J. Hematol., 62: 63-73, 1995.
6. Brasel, K., McKenna, H. J., Morrissey, P. J., Charrier, K., Morris, A. E., Lee, C. C., Williams, D. E., and Lyman, S. D. Hematological effects of Flt3 ligand in vivo in mice. Blood. 88: 2004-2012, 1996.
7. Maraskovsky, E., Brasel, K., Teepe, M., Roux, E. R., Lyman, S. D., Shortman, K., and McKenna, H. J. Dramatic increase in the numbers of functionally mature dendritic cells in Flt3 ligand-treated mice: multiple dendritic cell subpopulations identified. J. Exp. Med. 184: 1953-1962, 1996.
8. Chakravarty, P. K., Alfieri, A., Thomas, E. K., Beri, V., Tanaka, K. E., Vikram, B., and Guha, C. Flt3-ligand administration after radiation therapy prolongs survival in a murine model of metastatic lung cancer. Cancer Res., 59: 6028-6032, 1999.
9. Lynch, D. H., Andreasen, A., Maraskovsky, E., Whitmore, J., Miller, R. E., and Schuh, J. C. L. Flt3 ligand induces tumor regression and antitumor immune responses in vivo. Nat. Med., 3: 625-631, 1997.
10. Greenberg, N. M., DeMayo, F., Finegold, M. J., Medina, D., Tilley, W. D., Aspinall, J. O., Cunha, G. R., Donjacour, A. A., Matusik, R. J., and Rosen, J. M. Prostate cancer in a transgenic mouse. Proc. Natl. Acad. Sci. USA, 92: 3439-3443, 1995.
11. Foster, B. A., Gingrich, J. R., Kwon, E. D., Madias, C., and Greenberg, N. M. Characterization of prostatic epithelial cell lines derived from transgenic adenocarcinoma of the mouse prostate (TRAMP) model. Cancer Res., 57: 3325-3330, 1997.
12. Krill, D., Shuman, M., Thompson, M. T., Becich, M. J., and Strom, S. C. A simple method for the isolation and culture of epithelial and stromal cells from benign and neoplastic prostates. Urology, 49: 981-988, 1997.
13. Crocker, P. R., and Gordon, S. Mouse mΦ hemagglutinin (sheep erythrocyte receptor) with specificity for sialylated glycoconjugates characterized by a monoclonal anti-body. J. Exp. Med., 169: 1333-1346, 1989.